ALP (ALP) Stock Price & Analysis
ALP (ALP) fell 8.01% to USD 0.27 as of June 10, 2026 at 13:20 UTC, according to Nexqual real-time market data.
ALP last closed at USD 0.29; the session ranged USD 0.26–0.29 on volume of 5,886,367 shares. Market capitalization is $6.33M, with a 52-week range of USD 0.18–13.8 (NCM). Source: Nexqual, June 10, 2026 at 13:20 UTC.
Key Statistics (as of June 10, 2026 at 13:20 UTC)
| Price | USD 0.27 |
|---|---|
| Change | ▼ 8.01% (down) |
| Previous Close | USD 0.29 |
| Open | USD 0.28 |
| Day Range | USD 0.26 – 0.29 |
| 52-Week Range | USD 0.18 – 13.8 |
| Volume | 5,886,367 shares |
| Market Cap | $6.33M |
| Exchange | NCM |
Technical Analysis (ALP)
Nexqual's technical model rates ALP "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 13:20 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.48 (neutral) |
| vs SMA50 | Below (USD 0.3) |
| MACD | -0.01 (negative) |
Analyst Ratings (ALP)
Wall Street analysts rate ALP "None" based on 1 analysts, with a mean price target of USD 2 (range USD 2–2), per Nexqual as of June 10, 2026 at 13:20 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2 |
| High Target | USD 2 |
| Low Target | USD 2 |
Earnings (ALP)
| Next Earnings Date | 2026-06-10 |
|---|---|
| EPS Estimate | USD -0.35 |
| Revenue Estimate | $0 |
Source: Nexqual, June 10, 2026 at 13:20 UTC.
Financials & Fundamentals (ALP)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -311.00% |
| Current Ratio | 0.88 |
| Total Cash | $3.26M |
| Total Debt | $0 |
| Free Cash Flow | $1.82M |
Source: Nexqual, June 10, 2026 at 13:20 UTC.
Financial Health Score (ALP)
Nexqual rates ALP's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 13:20 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Critical — ROE -311%, ROA -34.3% |
Ownership (ALP)
| Insider Ownership | +5.89% |
|---|---|
| Institutional Ownership | +16.69% |
| Shares Outstanding | 23.53M |
| Float | 7.74M |
| Short % of Float | +10.86% |
Source: Nexqual, June 10, 2026 at 13:20 UTC.
Leadership (ALP)
ALP is led by Brittany Kaiser (age 36), CEO & Director, per Nexqual as of June 10, 2026 at 13:20 UTC.
| CEO & Director | Brittany Kaiser (age 36) |
|---|---|
| Chief Scientific Officer | Robert A. Kramer (age 72) |
| Executive Chairman & Chief Investment Officer | Fiorenzo A. Villani (age 54) |
| Chief Financial Officer | Wesley Allen Levitt C.F.A. (age 37) |
| Chief Technology Officer | Logan Ryan Golema |
Major Backers & Investors (ALP)
Notable institutional backers of ALP include Sabby Management, LLC, Shay Capital LLC, FNY Investment Advisers, LLC, according to Nexqual as of June 10, 2026 at 13:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sabby Management, LLC | 8.84% |
| Shay Capital LLC | 2.61% |
| FNY Investment Advisers, LLC | 0.76% |
| One68 Global Capital, LLC | 0.48% |
| Prelude Capital Management LLC | 0.36% |
| Warberg Asset Management LLC | 0.18% |
Source: Nexqual, June 10, 2026 at 13:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TNON | Tenon Medical, Inc. | USD 0.62 | ▲ 2.12% |
| VRAX | Virax Biolabs Group Limited | USD 0.19 | ▼ 11.64% |
| TGL | Treasure Global Inc. | USD 4.06 | ▼ 7.52% |
| SMX | SMX (Security Matters) Public L | USD 13.09 | ▲ 0.31% |
| BDRX | Biodexa Pharmaceuticals plc | USD 3.1 | ▼ 7.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:20 UTC. This page is informational and not investment advice.